New Key Statistics Module, Z-Score and F-Score
NYSE:RMD Key Ratios
Market Cap $ M | 34,573.71 |
Enterprise Value $ M | 35,805.88 |
P/E(ttm) | 33.99 |
PE Ratio without NRI | 30.47 |
Forward PE Ratio | 25.81 |
Price/Book | 7.11 |
Price/Sales | 7.43 |
Price/Free Cash Flow | 27.02 |
Price/Owner Earnings | 29.46 |
Payout Ratio % | 0.25 |
Revenue (TTM) $ M | 4,685.00 |
EPS (TTM) $ | 6.93 |
Beneish M-Score | -2.44 |
10-y EBITDA Growth Rate % | 12.50 |
5-y EBITDA Growth Rate % | 14.40 |
y-y EBITDA Growth Rate % | 13.30 |
EV-to-EBIT | 27.32 |
EV-to-EBITDA | 23.45 |
PEG | 2.12 |
Shares Outstanding M | 146.93 |
Net Margin (%) | 21.79 |
Operating Margin % | 29.54 |
Pre-tax Margin (%) | 27.00 |
Quick Ratio | 1.69 |
Current Ratio | 2.59 |
ROA % (ttm) | 14.98 |
ROE % (ttm) | 22.83 |
ROIC % (ttm) | 18.68 |
Dividend Yield % | 0.84 |
Altman Z-Score | 13.10 |
RMD Number of Guru Trades
RMD Volume of Guru Trades
Gurus Latest Trades with NYSE:RMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:RMD is held by these investors
Total 3
ResMed Inc Insider Transactions
No Available Data
News about NYSE:RMD
Total 0- 1